The Fellow on Call: The Heme/Onc Podcast cover image

Episode 056: Breast Cancer Series, Pt. 5-Breast Cancer Pharmacology

The Fellow on Call: The Heme/Onc Podcast

00:00

CDK4/6, SERDs, Everolimus: Metastatic Options

CDK4/6 inhibitors' mechanism and toxicities (neutropenia, QT, diarrhea) with abemaciclib management, fulvestrant IM dosing/administration, and everolimus stomatitis prevention using prophylactic dexamethasone mouthwash and dose‑modification rules.

Play episode from 37:29
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app